Alternatively, you can double click on "run" or "run.bat" on Windows. You can always download the most up-to-date pre-built JAR from GitHub Actions (link via nightly ...
The market seems to be content, for now at least, to keep betting big on AI. While the value of some companies integral to the AI boom like Nvidia, Oracle and Coreweave have seen their value fall ...
Big Tech’s huge investment in artificial intelligence is making investors nervous. But the technology continues to advance, buoying the bulls. By Brian O’Keefe Jensen Huang, C.E.O. of Nvidia, has seen ...
As we limp, downcast, into the end of another year, it's hard to avoid the conclusion that 2025 has been a momentous one, perhaps even a historic turning-point year. Not just for the terrible way it ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Abstract: Online collision-free trajectory generation within a shared workspace is fundamental for most multirobot applications. However, many widely-used methods based on model predictive control ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Abstract: Complicated deformation problems are frequently encountered in medical image registration tasks. Although various advanced registration models have been proposed, accurate and efficient ...
After years of explosive growth, experts are now pointing to potential cracks in AI’s foundation. Astronomical industry valuations, vast levels of investment and a promise of exponential progress have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback